1.TREATMENT OF MAJORLIN`S ULCER: THE ROLE OF COMBINATION CHEMOTHERAPY.
Journal of the Korean Society of Plastic and Reconstructive Surgeons 1997;24(4):761-765
No abstract available.
Drug Therapy, Combination*
;
Ulcer*
2.5-fluorouracil, epirubicin, cisplatin(FEP) and 5-fluorouracil, cisplatin(FP) combination chemotherapy for advanced pancreatic carcinoma.
Ki Hyeong LEE ; Won Ki KANG ; Chang In SUH ; Young Suk PARK ; Heung Tae KIM ; Yoon Koo KANG ; Hyo Jin KIM ; Dae Seog HEO ; Yung Jue BANG ; Yong Bum YOON ; Noe Kyeong KIM ; Yong Hyun PARK
Journal of the Korean Cancer Association 1991;23(2):315-322
No abstract available.
Drug Therapy, Combination*
;
Epirubicin*
;
Fluorouracil*
3.Combination chemotherapy for the treatment of multiple myeloma.
Hyo Jin KIM ; Chang In SEO ; Keun Chil PARK ; Heung Tae KIM ; Dae Seog HEO ; Yung Hue BANG ; Seonyang PARK ; Byoung Kook KIM ; Noe Kyeong KIM
Journal of the Korean Cancer Association 1992;24(4):577-585
No abstract available.
Drug Therapy, Combination*
;
Multiple Myeloma*
4.The Relationship between MDR1 Polymorphisms and the Response to Etoposide/Cisplatin Combination Chemotherapy in Small Cell Lung Cancer.
Ji Woong SOHN ; Shin Yup LEE ; Su Jung LEE ; Hyo Sung JEON ; Jae Hee LEE ; Jae Hyung PARK ; Eun Jin KIM ; Seung Ick CHA ; Chang Ho KIM ; Young Mo KANG ; Jae Tae LEE ; Tae Hoon JUNG ; Jae Yong PARK
Tuberculosis and Respiratory Diseases 2005;58(2):135-141
No abstract available.
Drug Therapy, Combination*
;
Small Cell Lung Carcinoma*
5.Treatment with augmented TAD combination chemotherapy and consolidation in patient with acute myelogenous leukemia.
Do Jin KIM ; Jung Sil WHANG ; Jong Ho WON ; Dae Sik HONG ; Hee Sook PARK ; Won Bae KIM
Journal of the Korean Cancer Association 1991;23(4):798-805
No abstract available.
Drug Therapy, Combination*
;
Humans
;
Leukemia, Myeloid, Acute*
6.Treatment of intermediate-grade non-Hodgkin's lymphoma with CAMP-MOB combination chemotherapy.
Chang In SUH ; Heung Tae KIM ; Dong Bok SHIN ; Jae Hoon LEE ; Dae Seog HEO ; Yung Jue BANG ; Seonyang PARK ; Byoung Kook KIM ; Noe Kyeong KIM
Journal of the Korean Cancer Association 1992;24(1):102-108
No abstract available.
Drug Therapy, Combination*
;
Lymphoma, Non-Hodgkin*
7.A Case of Intractable Hiccup Controlled by Combination Drug Therapy with Levosulpiride, Omeprazole and Baclofen.
Kyoung Rok KIM ; Mi Ra KIM ; Choong Kun HA ; Seong Hye CHOI
Journal of the Korean Neurological Association 2003;21(3):318-319
No abstract available.
Baclofen*
;
Drug Therapy, Combination*
;
Hiccup*
;
Omeprazole*
8.A randomized comparison of antiemetic effect of ondansetron versus MDL(metoclopramide/dexamethasone/lorazepam) in patients receiving cisplatin-based combination chemotherapy.
Young Hyuck IM ; Young Suk PARK ; Joungsoon JANG ; Jae Yong LEE ; Sungsoo YOON ; Dae Seog HEO ; Yung Jue BANG ; Noe Kyeong KIM
Journal of the Korean Cancer Association 1992;24(3):378-389
No abstract available.
Antiemetics*
;
Drug Therapy, Combination*
;
Humans
;
Ondansetron*
9.Gynecologic oncology group trials in uterine corpus malignancies: recent progress.
David Scott MILLER ; Louise P KING
Journal of Gynecologic Oncology 2008;19(4):218-222
The Gynecologic Oncology Group (GOG) has conducted multiple trials related to malignancies of the uterine corpus. Recently, several of these trials have been presented and/or published. Areas of focus included the feasibility of laparoscopic staging for endometrial cancer, the adjuvant management of locally advanced endometrial cancer, whole abdominal irradiation in maximally resected advanced endometrial carcinoma, and combination chemotherapy regimens for stage I and II carcinosarcoma after primary surgery and for advanced or recurrent carcinosarcoma. This article will discuss the background and details of each of these important advances.
Carcinosarcoma
;
Drug Therapy, Combination
;
Endometrial Neoplasms
;
Female
10.Gynecologic oncology group trials in uterine corpus malignancies: recent progress.
David Scott MILLER ; Louise P KING
Journal of Gynecologic Oncology 2008;19(4):218-222
The Gynecologic Oncology Group (GOG) has conducted multiple trials related to malignancies of the uterine corpus. Recently, several of these trials have been presented and/or published. Areas of focus included the feasibility of laparoscopic staging for endometrial cancer, the adjuvant management of locally advanced endometrial cancer, whole abdominal irradiation in maximally resected advanced endometrial carcinoma, and combination chemotherapy regimens for stage I and II carcinosarcoma after primary surgery and for advanced or recurrent carcinosarcoma. This article will discuss the background and details of each of these important advances.
Carcinosarcoma
;
Drug Therapy, Combination
;
Endometrial Neoplasms
;
Female
Result Analysis
Print
Save
E-mail